CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Mechanical TrombectomyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D007511 Ischemia NIH 0.50
D020521 Stroke NIH 0.32

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0001297 Stroke HPO 0.32

There is one clinical trial.

Clinical Trials


1 Endovascular Thrombectomy in COVID-19 Infected Patients: Intrahospital and Peri-operative Outcomes

About 5% of COVID-19 patients may present symptoms related to acute ischemic stroke (AIS). Treatment-management and outcomes related to mechanical thrombectomy (MT) for COVID-19 infected patients harboring large vessel occlusion is largely unknown. This multicentric study aims to investigate morbidity, mortality and neurological outcomes after MT performed in patients with COVID-19 infection.

NCT04406090 Ischemic Stroke Covid 19 Other: Mechanical Trombectomy
MeSH:Stroke Ischemia
HPO:Stroke

Primary Outcomes

Description: Intrahospital mortality after MT for COVID-19 infected patients harboring large vessel occlusion

Measure: Intrahospital mortality

Time: 1day

Description: short-term morbidity after MT for COVID-19 infected patients harboring large vessel occlusion

Measure: short-term morbidity

Time: 1 day

Secondary Outcomes

Description: Angiographic success after MT for COVID-19 infected patients harboring large vessel occlusion

Measure: Angiographic success

Time: 1 day


Related HPO nodes (Using clinical trials)